Pregnancy Zone Protein is Increased in the Alzheimer's Disease Brain and Associates with Senile Plaques.

Increased levels of pregnancy zone protein (PZP) were found in the serum of persons who later developed Alzheimer's disease (AD) in comparison to controls who remained dementia free. We suggested that this increase is due to brain derived PZP entering the blood stream during the early phase of the disease. Here we investigate the possible involvement of PZP in human AD pathogenesis. We observed increased PZP immunoreactivity in AD postmortem brain cortex compared to non-demented controls. In the AD cortex, PZP immunoreactivity localized to microglial cells that interacted with senile plaques and was occasionally observed in neurons. Our data link the finding of elevated serum PZP levels with the characteristic AD pathology and identify PZP as a novel component in AD.

[1]  H. Ahsan,et al.  Alpha‐2‐macroglobulin: A physiological guardian , 2013, Journal of cellular physiology.

[2]  S. Ortolano,et al.  LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease , 2012, Front. Physio..

[3]  J. Navaza,et al.  The crystal structure of human α2-macroglobulin reveals a unique molecular cage. , 2012, Angewandte Chemie.

[4]  A. Hofman,et al.  Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease. , 2011, Journal of proteome research.

[5]  T. Luider,et al.  Reproducibility of protein identification of selected cell types in Barrett's esophagus analyzed by combining laser-capture microdissection and mass spectrometry. , 2011, Journal of proteome research.

[6]  B. Melchior,et al.  A rose by any other name? the potential consequences of microglial heterogeneity during CNS health and disease , 2007, Neurotherapeutics.

[7]  N. Bogdanovic,et al.  Blood-brain barrier alterations in ageing and dementia , 2009, Journal of the Neurological Sciences.

[8]  C. Combs.  Inflammation and Microglia Actions in Alzheimer’s Disease , 2009, Journal of Neuroimmune Pharmacology.

[9]  J. Gilbert,et al.  An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3 , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  K. Akassoglou,et al.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis , 2009, Journal of Cell Science.

[11]  R. Deane,et al.  Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease , 2009 .

[12]  R. Kuljiš,et al.  The Role of Neuroimmunomodulation in Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.

[13]  T. Willnow,et al.  Lipoprotein receptors in Alzheimer's disease , 2006, Trends in Neurosciences.

[14]  E. Rogaeva,et al.  Genetic complexity of Alzheimer's disease: successes and challenges. , 2006, Journal of Alzheimer's disease : JAD.

[15]  Ralph A. Nixon,et al.  Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.

[16]  M. Tykocinski,et al.  Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. , 2004, Cellular immunology.

[17]  S. Schmidt,et al.  Presenilin Mutations in Familial Alzheimer Disease and Transgenic Mouse Models Accelerate Neuronal Lysosomal Pathology , 2004, Journal of neuropathology and experimental neurology.

[18]  María C Sánchez,et al.  Low‐density lipoprotein receptor‐related protein mediates in PC12 cell cultures the inhibition of nerve growth factor‐promoted neurite outgrowth by pregnancy zone protein and α2‐macroglobulin , 2002 .

[19]  S. L. Gonias,et al.  Distinct Binding Sites in the Structure of α2-Macroglobulin Mediate the Interaction with β-Amyloid Peptide and Growth Factors* , 2002, The Journal of Biological Chemistry.

[20]  P. Baron,et al.  Glial activation in Alzheimer’s disease: the role of Aβ and its associated proteins , 2001, Neurobiology of Aging.

[21]  G. Chiabrando,et al.  Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein (LRP). , 2001, Archives of biochemistry and biophysics.

[22]  G. Birkenmeier,et al.  α2-Macroglobulin-Mediated Degradation of Amyloid β1–42: A Mechanism to Enhance Amyloid β Catabolism , 2001, Experimental Neurology.

[23]  D. Kovacs.  α2-Macroglobulin in late-onset Alzheimer's disease , 2000, Experimental Gerontology.

[24]  N. Inestrosa,et al.  Expression of α2‐macroglobulin receptor/low density lipoprotein receptor‐related protein (LRP) in rat microglial cells , 2000, Journal of neuroscience research.

[25]  D. Strickland,et al.  The mammalian low-density lipoprotein receptor family. , 1999, Annual review of nutrition.

[26]  H. Teng,et al.  A study on the serum pregnancy zone protein levels in pregnant women and patients with gynecological tumors. , 1994, Chinese medical journal.

[27]  J. Nerbonne,et al.  Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. , 1994, The Journal of biological chemistry.

[28]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.

[29]  B. Strooper,et al.  α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease , 1993, Neurobiology of Aging.

[30]  T. Stigbrand,et al.  Differences in the proteinase inhibition mechanism of human alpha 2-macroglobulin and pregnancy zone protein. , 1992, European journal of biochemistry.

[31]  J. Bauer,et al.  Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[32]  U. Schreiter-Gasser,et al.  Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.

[33]  S. Moestrup,et al.  Binding and receptor-mediated endocytosis of pregnancy zone protein-proteinase complex in rat macrophages. , 1987, Biochimica et biophysica acta.

[34]  L. Sottrup-jensen,et al.  Characterization of human pregnancy zone protein. Comparison with human alpha 2-macroglobulin. , 1985, The Journal of biological chemistry.

[35]  J. Grudzinskas,et al.  Circulating levels of pregnancy zone protein: normal range and the influence of age and gender. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[36]  W. Stimson,et al.  Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations. , 1977, Clinical and experimental immunology.

[37]  J. M. Anderson,et al.  PREGNANCY-ASSOCIATED α2-GLYCOPROTEIN , 1977, The Lancet.